Recommended
More Related Content
What's hot
What's hot (20)
Similar to Dario health deck 2019
Similar to Dario health deck 2019 (20)
Recently uploaded
Recently uploaded (20)
Dario health deck 2019
- 1. DarioHealth Corp. Global Digital Health Platform NASDAQ: DRIO
- 2. Forward Looking Statements ⢠This presentation of DarioHealth Corp. (the âCompanyâ) and statements of our management or agents related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the âActâ). Statements which are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial condition, prospects and opportunities and are based upon information currently available to us and our management and their interpretation of what is believed to be significant factors affecting our business, including many assumptions regarding future events. Words such as âseek,â âintend,â âbelieve,â âplan,â âestimate,â âexpect,â âanticipate,â âwill,â âwould,â and other similar expressions all denote forward-looking statements within the meaning of the Act. ⢠Readers are cautioned that actual results, performance, liquidity, financial condition and results of operations, prospects and opportunities could differ materially and perhaps substantially from those expressed in, or implied by, these forward-looking statements as a result of various risks, uncertainties and other factors. Factors that could cause or contribute to such differences include, but are not limited to our compliance with regulatory requirements, the impact of current and any future competition, our current and future capital requirements and our ability to satisfy our capital needs through financing transactions or otherwise, our ability to manufacture, market and generate sales of our Dario⢠diabetes management solution, as well as other factors and risks discussed in the Companyâs filings (including the results of the companyâs commercial and regulatory plans for Darioâ˘) with the U.S. Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. ⢠In addition, readers are cautioned that any estimates, forecasts or projections contained in this presentation or as may be discussed by our management or agents have been prepared by our management in good faith on a basis believed to be reasonable. However, such estimates, forecasts and projections involve significant elements of subjective judgment and analysis and no representation can be made as to their attainability. No representation or warranty (express or implied) is made or is to be relied upon as a promise or representation as to our future performance. Readers are cautioned that such estimates, forecasts or projections have not been audited and have not been prepared in conformance with generally accepted accounting principles. 2
- 3. INVESTMENTS HIGHTLIGHT Exciting Growth Opportunities Global Market Opportunity Product Excellence Powerful Business Model
- 4. Dario at a glance
- 5. 60 Employees Serving customers in 6 countries 4 Regulatory bodies approvals/clearance 5 Countries fully reimbursed $9M in Yearly Sales run Rate* Founded in 2011 Offices in New York and Israel PROVEN SUCCESS AMONG THOUSANDS OF USERS WORLDWIDE Concrete ROI of $200 per user per month Since Q1 â 2015 *Partial insurance coverage Since Q3 - 2015 Since Q4 - 2015 Q3 - 2017 Q1 - 2015 Q1 - 2016 = Insurance coverage*Based on Q3-2018 numbers: Total collected of $2.21M
- 6. DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital health platform revolutionizing the way people manage their health across the chronic condition spectrum. By harnessing big data, machine learning, and automation, we have developed a novel approach of empowering individuals to analyze and personalize their lifestyles without having their disease slow them down. Already the highest rated diabetes solution by more than tens of thousands consumers who love the user-centered approach, DarioHealth is rapidly moving into new chronic conditions and geographic markets.
- 7. DARIO HEALTH - TRANSFORMING CHRONIC MANAGEMENT FROM TRADITIONAL & GENERIC TO DIGITAL & PERSONAL TRADITIONAL: Periodic data < General statistics based treatment < Independent factors - silo events < Driven by theories & independent professionals < DIGITAL: < Real-time streamed data < Personalized performance-based treatment < Dependency reaction of events < Driven by personalized data & AI technology VS
- 8. Users are in the driver seat of their lifestyle improvement USER CENTRIC Personalized User Experience
- 10. Heart Disease & Stroke $190B Diabetes $237B Obesity $147B Arthritis $140B Epilepsy $15.5B Hypertension $131B Source: Directs costs, CDC 2018 ANNUAL COST OF CHRONIC DISEASES IN THE USA 90% of the Nationâs $3.3 Trillion in annual Health Care expenditure is for people with CHRONIC and mental health conditions Alzheimer's $200B Cancer $174B
- 11. CDC 2018 2018 diabetes numbers (in millions) 480 Worldwide diabetes population 30.3 Americans, or 9.4% of the population, have diabetes. 1.25 American children and adults have Type1D. 86 Americans age 18 and older have prediabetes. 7.2 Americans with diabetes are undiagnosed. 1.5 Americans are diagnosed with diabetes every year.
- 12. Diabetes costs $327B ( 26%) Vs $245 billion in 2012 Direct Costs $237B ( 26%) $176 billion in 2012 Indirect Costs $90B ( 23%) $69 billion in 2012 DIABETES COST TO HEALTH CARE SERVICES $X * 2.3$X Health care cost for Americans with diabetes is 2.3 greater then those without. Source: ADA 2018
- 14. Hardware Application Data & Analytics Operation & Services INTEGRATED HOLISTIC APPROACH Unlike other companies who build their offering around a device and then cobble together a basic web interface and generic coaching, Dario's solution is powered by sophisticated software that enables members to have a highly unique experience with tailored coaching and support that goes beyond the basics of chronic condition management.
- 15. ADAPTIVE MODEL TO ANY CHRONIC CONDITION HYPERTENSION OBESITY PRE-DIABETES DIABETES
- 16. DEVICE & STRIPS DARIO APP SERVICE over DARIO ENGAGE DATA & AI OUR SOLUTION -DEVICE AGNOSTIC-
- 17. Nasdaq: DRIO 17 UNIQUE EXPERIENCE COMBINATION HARDWARE , SOFTWARE & SERVICE DIGITAL & LIVE COACHING
- 18. AWARENESS LEARNING TOOL & MOTIVATION SELF DIRECTED DIAGNOSED >> >> BEHAVIORAL CHANGE DARIO USERâS JOURNEY TO BEHAVIORAL MODIFICATION
- 19. PATIENTS PAYERS PROVIDERS PROFESSIONAL S DEVICE SERVICE DARIO APP DIGITAL INTERVENTION USER CENTRIC COMPONENTS DARIO ENGAGE CRM COACH BOT REPORTING PREDICTIVE TOOLS ANALYTICS CONTENT LIBRARY COACHING PROGRAM Multi Channel SMS, PUSH, In app DTC RETAILERS PAYERS DISTRIBUTERS CHANNELS INTEGRATED END 2 END HOLISTIC CARE APPROACH ONLINE SHOPBILLING DATA & AUTOMATION / AI JOURNEY LIBRARY LOYALTY ENGINE
- 20. Cost Containment & Medical Claims Savings *Showed on more then 17,000 users in clinical papers submitted to the ADA. 2.3% Reduction In HbA1C 12-43% Reduction in diabetes risks Yields substantial savings Cost more than $100,000 a year Hospital & ER Visits SAVING $230 Per patient per month MINIMIZING HEALTHCARE COSTS
- 21. Company Glucose Monitor App Open Platform Real-Time Coaching Dario Health Yes Yes Yes Yes Livongo Yes Dedicated handset Yes Not on the monitor itself No Yes mySugr No Yes No No Glooko No Yes Yes No WellDoc No Yes No No Omada No Yes No Yes 21 DARIO VS COMPETITORS
- 23. TRIPLE STAGE B2C FUNNEL REVENUE GENERATING MODEL OPTIMIZING CPA* vs. ARPU* GOAL: CPA efficiency via multiple distribution channels 45% Conversion to Paying Users GOAL: convert users into membership with higher ARPU and better clinical outcomes *CPA = Cost Per Acquisition *ARPU= Average Revenue Per User *PMPM = Per Member Per Month
- 24. 1st PMPM Offering Disposables only SUBSCRIPTION -2017- 2nd PMPM Offering Unlimited disposables, Service & Content MEMBERSHIP -2018- 3nd PMPM Offering CDE Personal coach PERFORMANCED BASED MEMBERSHIP Hypertension Program OTHER CONDITIONS -The Future- EVOLVING FROM DEVICE TO MEMBERSHIP OFFERING Best practices from digital industries brought to healthcare: ⢠Higher ARPU ⢠Higher contribution ⢠Better Clinical Outcomes SELL DEVICE & DISPOSAL SINGLE EVENT -2016- Today
- 25. HEALTHY MIX OF MEMBERSHIP PROGRAM IN THE DARIO SHOP Transforming the business from selling disposables to selling full package with physical and digital service driven by performance model: SAAS of the digital health, with higher contribution.
- 26. B2CB2B2C Providers Clinical, professional,CDE Partners Pharma, distributors, CROs Payers Insurer, employer Consumers Chronic & at risk ENABLE SCALABILITY: MULTIPLE CHANNELS WITH MULTIPLE STAKEHOLDERS B2PB2B
- 27. B2B Retail Mini-clinics, nurses Hospitals, IDNS Employers Distributors Endocrinologists Individual nurses Concierge practices B2P Pharmaceuticals B2C SALES STRUCTURE â REDUCING CPA Social Media Amazon Prime Payers Google Shopping
- 28. The voice of the patient
- 29. I have had Type 1 Diabetes for over 25 years and for most of this time I have really struggled to control my blood glucose readings. For most of this time my Hba1c was between 9 and 12, since using the Dario device my Hba1c has been as low as 7.3 and never higher than 8.5. Using the Dario has meant that I am managing my diabetes better than I ever have and I am only getting better and better the more I use it. I love the fact that the Dario device is so small and that it connects with my iPhone. It also helps me calculate my insulin based on my food. I can even scan bar-codes of food to find carbs. ROSSâS PERSONAL JOURNEY Ross, 42. Diagnosed in 1992. Brought his HbA1C levels from average of 9-12 down to 7.3-8.5. My son actually uses the Dario. He is 38 years old and handicapped. He knows how to test and I love the Dario because he has all the information and supplies that he needs right at hand and he can use his cell phone, which he does to call us with his blood sugars when he works, and it is synced with my husbandâs phone and my phone so that we know when he is low before he gets his snack. I like the fact that we can send his readings to the doctor before the visit so they can look over them. I like receiving the reports every month to see what his hypos and hypers have been so we can try to do a little better. I just think that the Dario is the best thing since sliced bread! Debbie, uses Dario for her handicapped son who was diagnosed in 1993 with T1D. Uses Dario to monitor her son in real-time. DEBBIEâS PERSONAL JOURNEY
- 32. REVENUE GROWTH (IN THOUSANDS) $67 $175 $273 $308 $568 $669 $728 $838 $1,007 $1,210 $1,375 $1,578 $1,756 $2,030 $1,888 $50 $355 $0 $500 $1,000 $1,500 $2,000 $2,500 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017 Q4 2017 Q1 2018 Q2 2018 Q3 2018 Revenue Deferred
- 33. *Model assumes $30 ARPU LONG TERM POTENTIAL 1% of US Market (30.3 M) = $120M* 1% of Worldwide (480 M) = $1.8B* 250K users = $100M
- 34. Source of Revenue Sales & marketing Investments Focus Data & AI Key Drivers of contribution Increase ARPU Product experience Existing & new users Expansion of the offering beyond Diabetes MULTIPLE DRIVERS FOR CONTINUOUS GROWTH Existing & new sales channels New types of users (CDEs) Increase LTV Conversion to PMPM Increase TAM & SAM
- 35. MAR 2018 FDA clearance for iPhone 7,8,X DarioHealth presents new data of more than 17,000 users at ADA Q2 Results â sales up 17% 14 quarters of growth in a row Complete significant private placement financing of approx. $11M Retail Agreement Giant Eagle Q3 Results â Hit $5.7M revenue first 9 month of 2018 Retail agreement Best Buy RECENT NEWS: CONTINUED GROWTH AND PROGRESS INTO B2B RETAIL RELATIONSHIPS
- 36. STRONG CAPITALIZATION, WELL POSITIONED TO SUPPORT GROWTH 36.6 M SHARES, HELD BY: Company is post significant financing and is financed into 2020 15 M WARRANTS EXERCISE PRICE OF $1.80 (EXPIRY: SEP 2019) EXERCISE PRICE OF $4.34 (EXPIRY: MAR 2021) EXERCISE PRICE OF $1.25 (EXPIRY: SEP 2021) *NO DEBT! $796K CEO $84K CCO $1,617K CFO $303K COO TOTAL $4,205K $1,405K BOARD MEMBER Management Investments (Cash and Salary paid in shares) 23.5% 31.9% 8.2% 36.4% FAMILY OFFICES & ACCREDITED INVESTORS VCs & INSTITUTIONS BOARD & MANAGEMENT PUBLIC
- 37. Limor Drezner| VP HR Limor is a professional HR & talent acquisition manager, holding vast experience from both corporate and startup companies and in her previous role served as Head of HR for Gett IL (As well as Microsoft, HP, Refael) Erez Raphael | CEO Mr. Raphael Digital Health Entrepreneur, has over 20 years of systems and software development experience in various industries including mobile, life science, medical device, health IT, mHealth and digital health solutions. Dror Bacher | COO Mr. Bacher has more than 17 years of software business experience, including managing positions in product development at both mobile and semi- conductor companies. Previously, he held numerous executive positions, including a leadership role at Amdocs. Zvi Ben-David | CFO Mr. Ben-David has 25 years of financial and accounting experience, particularly with medical device companies. Among his previous roles, he served as Corporate VP & CFO of Given Imaging. JoĂŁo Mendes-Roter | VP Marketing With over 20 years of experience, Ms. Mendes-Roter is a marketing executive and online digital expert in growth marketing and direct response. she held senior roles at 888 Holdings and gained valuable experience at RadView Software and Dun & Bradstreet. Yoav Shaked | Chairman Since 2011, Mr. Shaked has served as a partner at Sequoia Capital, a leading global venture capital firm. Mr. Shaked has more than 15 years of experience of founding several medical device companies. Olivier Jarry | President & CCO Mr. Jarry has managed innovation at the crossroads of technology, healthcare and patient-centricity for three decades on five continents. He has had several executive roles in life sciences multinationals such as leading the global Diabetes Care division of Bayer. Professor Itamar Raz | Medical Director Mr. Raz, is a full professor of Internal Medicine and was the Head of the Diabetes Unit at Hadassah University Hospital 2000-2015, Prof. Raz is currently serving as head of the Israeli National Council of Diabetes and is the initiator and leader of the National Diabetes Prevention and Care Plan in Israel. Michal Hershkovitz | VP Clinical & Regulatory Michal has managed global regulatory strategy design and implementation as well as global clinical studies for three decades in the Medical Devices and Pharmaceutical industry. Allen Kamer | Board Member Allen is a successful entrepreneur and experienced corporate executive in the healthcare and medical informatics space. Allen has nearly 25 years of experience in converting health information to health intelligence and delivering solutions that improve care delivery, quality and cost-effectiveness. EXECUTIVETEAMANDBOARDMEMBERS Yael Lipskin-Moshe| Director of Product Yael is a professional product manager, specializing in mobile apps. Backed by 14 years of experience, working on products of Wix, Gett, Macabi Health. Yael combines both vision and creativity in crafting the user experience that will best serve our customer needs. Yinon Amir | Head of Software Mr. Amir brings vast experience in software development, engineering practices, digital technologies, solution, architecture and design, as well as large scale projects management, and customer delivery management, as a senior management position in Amdocs Glen Moller| Board Member Glen Moller is CEO at BehaveCare, Inc. In his past career he held the position of President-Health Plans at Concerto Health Services, Inc., CEO Medicare Division at Centene Corp., CEO at ArroHealth, Chief Operating Officer Express Scripts Insurance Co. CMO for Oxford Health Plans.
- 38. Commercial Office 142 W 57th Street 8th Floor New York, NY 10019 USA partnershipgroup@dariohealth.com www.dariohealth.com R&D Center 8 Hatokhen Street North Industrial Park Caesarea 389000 Israel